The First-and-Only Completed Stemless Reverse IDE in the USA DALLAS, Jan. 27, 2022 /PRNewswire/ — FX has completed the enrollment for their…
Read More »DALLAS, December 5, 2018 /PRNewswire/ — FX Shoulder USA, Inc. will begin in December 2018 the FDA approved Investigational Device Exemption (IDE) clinical study of…
Read More »